16 Jun JOHNS HOPKINS STUDY PROBES “SACRED MUSHROOM”
The continuing study at Johns Hopkins University School of Medicine on psilocybin and its potential in the treatment of anxiety and depression in those facing lifeÂ threatening cancer is the topic in the journal Â Psychopharmacology . Please follow the links to the Â press release and the Yahoo news story for more information.
Also take note of an observation made by “Jerome Jaffe, M.D., of the University of Maryland School ofÂ Medicine, who served as the first White House â€œDrug Czarâ€ and has also been aÂ consultant to the World Health Organization on drug issues.” â€œThe HopkinsÂ psilocybin studies clearly demonstrate that this route to the mystical is not to be walkedÂ alone. But they have also demonstrated significant and lasting benefits. That raises twoÂ questions: Could psilocybin-occasioned experiences prove therapeutically useful, forÂ example in dealing with the psychological distress experienced by some terminalÂ patients? And should properly-informed citizens, not in distress, be allowed to receiveÂ psilocybin for its possible spiritual benefits, as we now allow them to pursue otherÂ possibly risky activities such as cosmetic surgery and mountain-climbing?â€
The Hopkins Â study is on going and recruitingÂ volunteers.